Saba Capital Management, L.P. Bausch Health Companies Inc. Transaction History
Saba Capital Management, L.P.
- $4.69 Billion
- Q3 2024
A detailed history of Saba Capital Management, L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Saba Capital Management, L.P. holds 94,000 shares of BHC stock, worth $725,680. This represents 0.08% of its overall portfolio holdings.
Number of Shares
94,000Holding current value
$725,680% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BHC
# of Institutions
258Shares Held
255MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$268 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$227 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$204 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$121 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$100 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.79B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...